Skip to content
★ Sign in to follow
JR

John Robert Zibert

Coegin Pharma AB
Total declarations
5
Company
1
▲ Purchases (1 ops.)
—
▼ Sales (0 ops.)
—

Latest filing published 01 Oct 2024 for Coegin Pharma AB, €13k.

Filing timeline

BuySale
John Robert Zibert

Insider track record

Disclosed buys
1
Disclosed sells
0
Signal history

Closed purchases

Market purchases
1

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

John Robert Zibert: trading record in brief

John Robert Zibert is a declared insider of Coegin Pharma AB, with filings sourced from Finansinspektionen. In total, 5 filings cover trades dated from 27 September 2024 to 30 September 2024.

No open-market sale appears; the market trades are 1 purchase. No amount is published for 1 filing, which the totals therefore leave out. Unlike grants, an open-market purchase is paid for by the insider, at the market price.

Most recently, on 1 October 2024, the filings show a transaction worth €13k in Coegin Pharma AB. The last insider purchase was made public on 1 October 2024, 768 days ago. Typically, a trade is published a median of 4 days after it takes place. For comparison, MAR article 19 gives managers three business days to notify a trade. These figures are compiled from regulatory filings published by Finansinspektionen. They describe what insiders did and are not a recommendation.

Companies and markets linked to John Robert Zibert

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations5 total
  • ●
    Annan ledande befattningshavareExecutivesCoegin Pharma AB
    149,760 SEK10FI-SE
    38,400 shares@ SEK 3.9091.5% of flowAktieISIN SE0020357754FI:csv-8a585a2d32cbd0e68af2
  • ●
    Annan ledande befattningshavareExecutivesCoegin Pharma AB
    13,989 SEK3FI-SE
    3,587 shares@ SEK 3.908.5% of flowAktieISIN SE0020357754FI:csv-778fa7e45cf1400d9a3e
  • ▲
    Annan ledande befattningshavareExecutivesCoegin Pharma AB
    0FI-SE
    38,400 shares0WarrantISIN SE0021513660FI:csv-21377f65fc2fdb42217d
    Canonical exit: 26 Dec 2024 (T+90)
  • ●
    Annan ledande befattningshavareExecutivesCoegin Pharma AB
    0FI-SE
    3,587 shares0WarrantISIN SE0021513660FI:csv-840dadc3ef16b5317c81
  • ●
    Annan ledande befattningshavareExecutivesCoegin Pharma AB
    0FI-SE
    38,400 shares0WarrantISIN SE0021513660FI:csv-5bda58b9680f7ca9dea8

5 of 5 declarations